Overall Status

Completed (10)

Recruiting (7)

Active, not recruiting (5)

Not yet recruiting (2)

Terminated (2)

Withdrawn (2)

Unknown status (1)

Phase

phase 2 (10)

phase 1 (8)

early phase 1 (4)

phase 1/phase 2 (3)

n/a (2)

phase 3 (2)

Study Documents

Intervention Type

drug (29)

biological (9)

procedure (7)

genetic (6)

radiation (3)

Funder Type

Other (26)

Industry (3)

Study Type

Interventional (29)

cytoxan

Showing 26 - 29 of 29

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Lymphoid Hematological Malignancies, Umbilical Cord Blood Transplant Trial (drug, radiation, procedure)

Withdrawn

Lymphoid Hematological Malignancies
Umbilical Cord Blood Transplant

Cytoxan
+3 more

(no location specified)

Dec 11, 2013

Breast Cancer Trial in Boston (Herceptin, Taxol, Adriamycin)

Completed

Breast Cancer

Herceptin
+3 more

Boston, Massachusetts
+1 more

Feb 15, 2013

Breast Cancer Trial in Houston (Herceptin, Taxol, Fluorouracil)

Completed

Breast Cancer

Herceptin
+4 more

Houston, Texas

UT MD Anderson Cancer Center

Jul 19, 2012

Multiple Myeloma Trial in Little Rock (Thalidomide, Dexamethasone, Cytoxan)

Completed

Multiple Myeloma

Thalidomide
+5 more

Little Rock, Arkansas

University of Arkansas for Medical Sciences/MIRT

Jul 1, 2010